Abhishaike Mahajan, an AI researcher at Noetik, discussed the application of machine learning in drug development, spanning preclinical, clinical, and postclinical stages. His career includes using AI for chronic disease prediction at Anthem, developing improved viruses for genetic therapy delivery at Dyno Therapeutics, and currently focusing on predicting patient responses to cancer drugs by analyzing tumor microenvironments. Mahajan highlighted the challenges and opportunities in biological machine learning, particularly in generating novel molecules and understanding complex biological systems where ground truth is not readily available. AI
RANK_REASON This is an interview with an AI researcher discussing applications in drug development, which falls under commentary.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
